Financial The World Now Has Three People Worth More Than $100 Billion Each

The World Now Has Three People Worth More Than $100 Billion Each
Small Cap Biotech Stocks See Boost From Large Cap M&A
Trying to solve for Stock Price given d1 using BSM model...
More spent on S&P 500 buybacks than all 2018 R&D
An Overview of Facebook's Libra
Investment Matriarchs Are Bullish on US Stocks
The CEO of State Street explains why he's going toe-to-toe with Bloomberg and BlackRock by offering asset managers a one-stop technology shop
Beyond Meat shares are on a wild roller coaster ride

The World Now Has Three People Worth More Than $100 Billion Each

Posted: 19 Jun 2019 05:28 AM PDT

submitted by /u/mynameis_neo
[link] [comments]

Small Cap Biotech Stocks See Boost From Large Cap M&A

Posted: 19 Jun 2019 04:08 AM PDT

Cancer has been a problem plaguing society for at least half a century. However, the fight to defeat cancer has picked up steam in the 21st century. More and more companies are making it their missions to develop treatments for many forms of cancer. From penny stocks to large-cap stocks, biotechnology companies are breaking new ground.

Original article : Small Cap Biotech Stocks See Boost From Large Cap M&A

GT Biopharma Inc. (GTBP) is a small-cap biotech company that creates immune-oncology products. They utilize a technology platform that combines antibody-drug linkers to single-chain, bi-, tri-, and tetra-specific scFv constructs to produce treatments. One example is for carcinoma, called OXS-1615, which is a tetraspecific treatment.

Recently, GT Biopharma has been making advances for their GTB-1550 treatment. This treatment aims to treat Non-Hodgkin's Lymphoma and Leukemia. They recently announced the results of GTB-1550's phase I and II clinical trials. The results showed positive results including one patient becoming cancer-free post treatment.

submitted by /u/DRay82
[link] [comments]

Trying to solve for Stock Price given d1 using BSM model...

Posted: 19 Jun 2019 06:46 AM PDT

Working on some homework... This is the exact question:

"You are considering the purchase of a 3 month European put option on Jet Blue's stock which has an announced dividend payment of $1.5 in two months. You are given the following information:

The strike price is $50
The continuously compounded risk free rate is 10%
The annual volatility on the stock is 0.3
d2 = -0.1086"

I was able to find d1 since d2 = d1 - (volatility * SQRT(time))

I rearranged that so that d1 = d2 + (volatility * SQRT(time))

I got d1 = 0.0432

If I'm on the right track, it should be possible to rearrange the actual formula for d1 to get the stock price.

d1 = (ln(S / K) + (r - y + σ²/2) * T) / (σ * SQRT(T))

This is what I got plugging in the variables:

d1 = (ln(S / 50) + (0.1 - (1.50/S) + 0.3² / 2) * 0.25) / (0.3 * SQRT (0.25))

This is where I get stuck. How can I rearrange this such that it solves for S rather than d1? I'm doing this in Excel if that makes any difference. Any help is appreciated.

submitted by /u/hgravesc
[link] [comments]

More spent on S&P 500 buybacks than all 2018 R&D

Posted: 19 Jun 2019 09:01 AM PDT